Description
ITRA FORTE is a potent antifungal formulation combining Fluconazole (150mg) and Itraconazole (200mg) to deliver a synergistic effect against a broad spectrum of fungal pathogens, including Aspergillus species. This unique combination enhances treatment outcomes, especially for patients who have shown resistance to other azole therapies.
Key Features:
- Synergistic Action: The combined effect of Fluconazole and Itraconazole provides a wider range of antifungal activity, making it particularly effective for challenging infections.
- Broad Spectrum Efficacy: Proven effective against serious fungal infections, including Aspergillosis, Cryptococcosis, Histoplasmosis, Blastomycosis, Sporotrichosis, and Paracoccidioidomycosis.
- Superior Efficacy: ITRA FORTE has shown greater safety and efficacy compared to Ketoconazole and offers superior results over Griseofulvin in treating dermatophyte onychomycosis.
- Long-lasting Effect: Achieves high concentrations in skin and nails that can persist for up to three months after the conclusion of therapy, ensuring prolonged protection.
- Rapid Symptomatic Relief: Provides quicker relief from symptoms associated with fungal infections, improving the quality of life for patients.
ITRA FORTE is the ideal choice for effective and comprehensive treatment of resistant fungal infections, offering both immediate and sustained results for optimal patient care.